Renal Cell Carcinoma and it's Surviving Phase [Large Print]

By Annette Purseley

Kidney Renal Carcinoma
This is a major global health issue. Although treatments with immune checkpoint blockade and tyrosine kinase inhibitors are producing promising outcomes either alone or in combination, failures are quite common due to intratumor heterogeneity and the development of drug resistance. There are numerous subtypes of renal cell carcinoma. Up to 70-80% of renal growths are clear cell renal cell carcinomas, a clinically forceful cancer subtype connected to VHL quality inactivation. Next in frequency is the category of papillary renal cell carcinoma, which includes a jigsaw of old and new entities with vague limits, some of which are still unclear. The hybrid tumors and oncocytic neoplasms, also known as the chromophobe-oncocytoma duality, have not yet been adequately profiled. Lastly, the current picture of renal cell neoplasia is completed by a growing number of extremely rare renal tumors that are associated with particular molecular signatures. From the intimate fundamental mechanisms governing this disease to the clinical practice principles of their diagnoses and treatments, RCC are examined from a variety of perspectives in this Special Issue of Cancers. The interested reader will be provided with excellent reviews and the opportunity to contact with some of the most recent findings.

• Format: Paperback
• Large Print: Yes
• Language: English
• ISBN: B0BVDJDB1D
• ISBN13: 9798376943625
• Release Date: February 2023
• Publisher: Independently Published
• Length: 46 Pages
• Weight: 0.17 lbs.
• Dimensions: 0.1" x 6.0" x 9.0"